Home » Topics » Disease categories and therapies » Cardiovascular

Cardiovascular
RSS

Provensis continues work to lift Varisolve clinical hold

Oct. 6, 2004

Optically active calcium antagonists and their use in hypertension and other disorders

Oct. 5, 2004

Two-year follow-up data for TAXUS IV trial

Oct. 4, 2004

Oxis International licenses BXT-51072 and compounds to HaptoGuard

Oct. 4, 2004

Phase I/II study for KAI-9803 in reperfusion injury

Oct. 4, 2004

Phase II results on the efficacy of Deltavasc in peripheral artery disease

Oct. 4, 2004

Preliminary data support the use of AGI-1067 in coronary atherosclerosis

Sep. 30, 2004

Preliminary results from phase II study of Furosemide GR

Sep. 30, 2004

Dosing commences in study of controlled-release oral RSD-1235

Sep. 29, 2004

Novel HDL-increasing agents developed at Eisai

Sep. 27, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
CINP 2026: Gut microbiota could predict antidepressant response
BioWorld
The gut microbiota may be altered in people with depression as a result of treatment. These microorganisms reorganize differently in individuals who respond to...
Deep brain stimulation from the shallows: tomorrow’s BCI technology?
BioWorld
Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...
Ascending BCI systems deepen national security, ethical concerns
BioWorld
Ready or not, the future has arrived. Novel AI and brain-computer interface (BCI) systems are no longer confined to the realm of science fiction. As an...